Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality.

Autor: Commiesie E; National Tuberculosis Programme, Paramaribo.; Anton de Kom University, Paramaribo, Suriname., Stijnberg D; National Tuberculosis Programme, Paramaribo.; Anton de Kom University, Paramaribo, Suriname., van den Boogaard J; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Gopie F; Anton de Kom University, Paramaribo, Suriname.; Academic Hospital, Paramaribo, Suriname., Vreden S; Anton de Kom University, Paramaribo, Suriname., de Vries G; Anton de Kom University, Paramaribo, Suriname.; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Publikováno v: IJTLD open [IJTLD Open] 2024 Jan 01; Vol. 1 (1), pp. 34-40. Date of Electronic Publication: 2024 Jan 01 (Print Publication: 2024).

Should treatment of low-level mono-resistant tuberculosis be different?

Autor: Gopie FA; Anton de Kom University of Suriname, Faculty of Medical Sciences, Flustraat 4, United States., Commiesie E; Anton de Kom University of Suriname, Faculty of Medical Sciences, Flustraat 4, United States., de Lange WCM; Anton de Kom University of Suriname, Faculty of Medical Sciences, Flustraat 4, United States., van Soolingen D; Anton de Kom University of Suriname, Faculty of Medical Sciences, Flustraat 4, United States., Vreden SGS; Anton de Kom University of Suriname, Faculty of Medical Sciences, Flustraat 4, United States., de Vries G; Anton de Kom University of Suriname, Faculty of Medical Sciences, Flustraat 4, United States.

Publikováno v: Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2021 Apr 30; Vol. 23, pp. 100241. Date of Electronic Publication: 2021 Apr 30 (Print Publication: 2021).

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

Autor: Gopie FA; Academic Hospital Paramaribo, Paramaribo, Suriname.; Faculty of Medical Sciences, Anton de Kom University of Suriname, Paramaribo, Suriname., Commiesie E; National Tuberculosis Program, Paramaribo, Suriname., Baldi S; Central Laboratory, Paramaribo, Suriname., Kamst M; National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Kaur D; Massachusetts Supranational TB Reference Laboratory, University of Massachusetts Medical School, Jamaica Plane, MA, USA., de Lange WCM; Department Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, the Netherlands., Pinas PS; Central Laboratory, Paramaribo, Suriname., Stijnberg D; National Tuberculosis Program, Paramaribo, Suriname., Wongsokarijo M; Central Laboratory, Paramaribo, Suriname., Zijlmans CWR; Faculty of Medical Sciences, Anton de Kom University of Suriname, Paramaribo, Suriname., de Zwaan R; National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., van Soolingen D; National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Vreden SGS; Academic Hospital Paramaribo, Paramaribo, Suriname., de Vries G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Publikováno v: Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2021 Jan 29; Vol. 23, pp. 100222. Date of Electronic Publication: 2021 Jan 29 (Print Publication: 2021).